| Application no. and date | 19207534.9 (espacenet) (Federated) (European Patent Register), 20091002 | | Patent/reg. no. and date | DK/EP 3628319, 20240214 | | Publication date | 20200401 | | Priority no. and date | US 102349 P, 20081002 | | EP pub. no. and date |
EP 3628319 20200401 | | Effective date | | | Applicant/owner | Salix Pharmaceuticals, Ltd., 400 Somerset Corporate Blvd.
Bridgewater, NJ 08807, US | | Applicant ref. no. | BB242153EPDK | | Inventor | FORBES, William, 1008 Heydon Court
Raleigh, NC 27164, US | | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | | Opponent | | | IPC Class | A61K 31/08 (2006.01) , A61K 31/352 (2006.01) , A61K 31/395 (2006.01) , A61K 31/4164 (2006.01) , A61K 31/426 (2006.01) , A61K 31/437 (2006.01) , A61K 31/4439 (2006.01) , A61K 31/606 (2006.01) , A61K 31/7016 (2006.01) , A61K 31/785 (2006.01) , A61K 38/14 (2006.01) , A61K 38/31 (2006.01) , A61K 45/06 (2006.01) , A61P 1/16 (2006.01) | | Title | BEHANDLING AF HEPATISK ENCEFALOPATI VED ANVENDELSE AF RIFAXIMIN | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
